Evidence map›Paper›PMID 33591992›Full record

ArticlePLoS neglected tropical diseases2021

Comparison of clinical characteristics of Zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico.

Pablo F Belaunzarán-Zamudio, Allyson Mateja, Paola Del Carmen Guerra-de-Blas, Héctor A Rincón-León, Karla Navarro-Fuentes, Emilia Ruiz-Hernández, Sandra Caballero-Sosa, Francisco Camas-Durán, Zoila Priego-Smith, José G Nájera-Cancino and 9 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

Pablo F Belaunzarán-ZamudioDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0003-4775-4734
Allyson MatejaClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.ORCID 0000-0002-2810-478X
Paola Del Carmen Guerra-de-BlasThe Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.ORCID 0000-0003-3050-6865
Héctor A Rincón-LeónUnidad de Medicina Familiar No.11, Instituto Mexicano del Seguro Social, Tapachula, Chiapas, Mexico.ORCID 0000-0003-0715-200X
Karla Navarro-FuentesUnidad de Medicina Familiar No.11, Instituto Mexicano del Seguro Social, Tapachula, Chiapas, Mexico.ORCID 0000-0002-6894-8872
Emilia Ruiz-HernándezHospital General de Tapachula, Tapachula, Chiapas, Mexico.
Sandra Caballero-SosaClínica Hospital Dr. Roberto Nettel Flores, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Tapachula, Chiapas, Mexico.ORCID 0000-0001-8494-5551
Francisco Camas-DuránClínica Hospital Dr. Roberto Nettel Flores, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Tapachula, Chiapas, Mexico.
Zoila Priego-SmithClínica Hospital Dr. Roberto Nettel Flores, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Tapachula, Chiapas, Mexico.
José G Nájera-CancinoHospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
Alexander López-RobleroHospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.ORCID 0000-0002-3697-4523
Karina Del Carmen Trujillo-MurilloHospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.ORCID 0000-0002-2691-2273
John H PowersNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.ORCID 0000-0002-5150-5119
Sally HunsbergerNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
Sophia SiddiquiNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.ORCID 0000-0002-1421-0194
John H BeigelNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.ORCID 0000-0002-4879-4941
Raydel Valdés-SalgadoWestat, Rockville, Maryland, United States of America.ORCID 0000-0001-5435-1090
Guillermo Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0003-3708-9654
Mexican Emerging Infectious Diseases Clinical Research Network (LaRed)
National Institute of Allergy and Infectious Diseases · USHospitales Regionales de Alta Especialidad · MXInstitute for Social Security and Services for State Workers · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXMexican Social Security Institute · MXFrederick National Laboratory for Cancer Research · USUniversidad del Tacana · MXWestat (United States) · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI PENDLETON, RICHARD · 2019 to 2025
$3932.6M
CCR NIH HHS HHSN261200800001CNCI NIH HHS 75N91019D00024NCI NIH HHS HHSN261200800001ENIAID NIH HHS HHSN272200900001CNIAID NIH HHS HHSN272200900031C
6 · The paper itself

Abstract

backgroundOur purpose was to provide a detailed clinical description, of symptoms and laboratory abnormalities, and temporality in patients with confirmed Zika and dengue infections, and other acute illnesses of unidentified origin (AIUO). METHODS/ PRINCIPAL

findingsThis was a two-year, multicenter, observational, prospective, cohort study. We collected data from patients meeting the Pan American Health Organization's modified case-definition criteria for probable Zika infection. We identified Zika, dengue chikungunya by RT-PCR in serum and urine. We compared characteristics between patients with confirmed Zika and dengue infections, Zika and AIUO, and Dengue and AIUO at baseline, Days 3,7,28 and 180 of follow-up. Most episodes (67%) consistent with the PAHO definition of probable Zika could not be confirmed as due to any flavivirus and classified as Acute Illnesses of Unidentified Origin (AIUO). Infections by Zika and dengue accounted for 8.4% and 16% of episodes. Dengue patients presented with fever, generalized non-macular rash, arthralgia, and petechiae more frequently than patients with Zika during the first 10 days of symptoms. Dengue patients presented with more laboratory abnormalities (lower neutrophils, lymphocytosis, thrombocytopenia and abnormal liver function tests), with thrombocytopenia lasting for 28 days. Zika patients had conjunctivitis, photophobia and localized macular rash more frequently than others. Few differences persisted longer than 10 days after symptoms initiation: conjunctivitis in Zika infections, and self-reported rash and petechia in dengue infections.

conclusionsOur study helps characterize the variety and duration of clinical features in patients with Zika, dengue and AIUO. The lack of diagnosis in most patients points to need for better diagnostics to assist clinicians in making specific etiologic diagnoses.

Indexed as

AdolescentAdultAgedChikungunya FeverChikungunya virusChildCohort StudiesDengueDengue VirusFemaleFever of Unknown OriginHumansMaleMexicoMiddle AgedProspective Studies

Identifiers

PMID33591992
PMCPMC7909682
OpenAlexW3130171721

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.